表紙
市場調查報告書

末稍血管設備的全球市場(2020年∼2026):MedSuite

Peripheral Vascular Devices Market Report Suite | Global | 2020-2026 | MedSuite

出版商 iData Research Inc. 商品編碼 953939
出版日期 內容資訊 英文 845 Pages
商品交期: 最快1-2個工作天內
價格
末稍血管設備的全球市場(2020年∼2026):MedSuite Peripheral Vascular Devices Market Report Suite | Global | 2020-2026 | MedSuite
出版日期: 2020年07月22日內容資訊: 英文 845 Pages
簡介

全球末稍血管設備市場,2019年是119億美金。該市場,在預測期間內預計以5.2%的年複合成長率增加,達到169億美元。最大市場的血管支架,預計受到全球認可的醫療機關的最後指南很大的影響,對EVAR的數十年的趨勢,有開放式手術的修復逆行的可能性。

本報告提供全球末稍血管設備市場的相關調查,市場趨勢和開發,成長及阻礙因素,產品的評估,各設備、地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

目錄

圖的清單

表的清單

摘要整理

全球末稍血管設備市場市場概要

競爭分析

趨勢

市場開發

手術數量

包含的市場

版本履歷

調查手法

疾病概要

  • 基本的解剖學
  • 病的治療和診斷
    • 主動脈瘤
    • 動脈粥狀硬化
    • 週邊動脈疾病(PAD)
    • 深部靜脈血栓症(DVT)
    • 肺動脈栓塞(PE)
  • 患者的人口統計
    • 主動脈瘤
    • 動脈粥狀硬化
    • 週邊動脈疾病(PAD)
    • 深部靜脈血栓症(DVT)
    • 肺動脈栓塞(PE)

產品的評估

  • 簡介
  • 產品系列
    • 末梢血管支架
    • 靜脈支架
    • 經皮經管血管成形術(PTA)球囊
    • 藥物塗料球囊
    • 旋切術設備
    • 慢性完全閉塞(CTO)設備
    • 血管內碎石術
    • 外科的移植
    • 血管支架
    • 栓塞保護裝置
    • 末梢血栓管理設備
    • 下腔靜脈濾器
    • 頸動脈分流術
    • 診斷及介入導管
    • 診斷及介入導管導引線
    • 介紹者的鞘
    • 血管閉合設備(VCD)
    • 經導管栓塞治療裝置
    • 週邊靜脈導管
  • 與法規的問題法規
  • 臨床試驗
    • Abbott
    • B. Braun
    • Boston Scientific
    • C.R. Bard (BD)
    • Cardinal Health
    • Cook Medical
    • Cordis (Cardinal Health)
    • Medtronic
    • Shockwave Medical, Inc.
    • Surmodics
    • Terumo Corporation
    • W.L. Gore
    • 其他

全球末稍血管設備市場市場概要

  • 簡介
    • 動脈粥狀硬化
    • 週邊動脈疾病(PAD)
  • 市場概要
  • 各地區的趨勢分析
    • 全球趨勢
    • 北美
    • 南美
    • 西歐
    • 中央、東歐
    • 中東
    • 非洲
    • 亞太地區
  • 成長及阻礙因素
    • 市場成長要素
    • 阻礙市場要素
  • 競爭市場佔有率分析
  • 合併和收購
  • 企業簡介
    • Abbott
    • Becton Dickinson (BD)
    • Boston Scientific
    • Cardinal Health
    • Cook Medical
    • Maquet
    • Medtronic
    • Teleflex
    • Terumo
    • W.L. Gore
  • SWOT分析
    • Abbott
    • B. Braun
    • Boston Scientific
    • BD
    • Cardinal Health
    • Cook Medical
    • Integra Lifesciences
    • Maquet
    • Medtronic
    • Merit Medical
    • Phillips
    • Teleflex
    • Terumo Corporation
    • W.L. Gore

手術數量

  • 簡介
  • 手術
    • 世界
    • 北美
    • 南美
    • 西歐
    • 中央及東歐
    • 中東
    • 非洲
    • 亞太地區

北美市場

南美市場

西歐市場

中東歐市場

中東市場

非洲市場

亞太地區市場

附錄:全球碎石術市場

  • 簡介
  • 手術
    • 全球手術
  • 市場概要
  • 市場分析與預測
    • 全球碎石術市場

簡稱

目錄
Product Code: iDATA_GLPV20_MS

The global peripheral vascular device market was valued at $11.9 billion in 2019. This is expected to increase over the forecast period at a CAGR of 5.2% to reach $16.9 billion.

In 2020, the global peripheral vascular market will be defined by the final outcomes of the guidelines made by the National Institute of Health and Care Excellence (NICE) in the United Kingdom. This organization released original draft guidelines in 2018 suggesting that endovascular aneurysm repair (EVAR) not be performed on pre-ruptured aneurysms. The largest market, stent grafts, is expected to be significantly impacted by the globally recognized health body's final guidelines, and the decades-long trend towards EVAR might be reversed to open surgical repair.

The Asia Pacific and Latin American markets are characterized by rapidly expanding healthcare systems and growth in local treatment rates. These regions have been noted for their moderate to low pricing (excluding Japan) and are expected to achieve the highest overall growth in the peripheral vascular market. Within all regions, the venous treatment market has been growing explosively, and separate analyses estimate that the market will represent approximately 25%-33% of the bare metal stent market value by the end of 2026. This massive increase in global procedures is also increasing the total introducer sheath, guidewire, and catheter markets.

The full report suite on the global market for peripheral vascular devices includes peripheral vascular stents, percutaneous transluminal angioplasty (PTA) balloon catheters, drug-coated balloons (DCBs), atherectomy disposables, chronic total occlusion (CTO) devices, stent grafts, surgical grafts, diagnostic and interventional guidewires, diagnostic and interventional catheters, introducer sheaths, vascular closure devices (VCDs) and peripheral IVUS catheters. An analysis on intravascular lithotripsy balloon catheters is included as an appendix. Many of these devices can be used for treating either coronary arterial disease or peripheral arterial disease (PAD). However, only devices used for peripheral procedures are included in this report.

TABLE OF CONTENTS

TABLE OF CONTENTS

LIST OF FIGURES

LIST OF CHARTS

EXECUTIVE SUMMARY

GLOBAL PERIPHERAL VASCULAR DEVICE MARKET OVERVIEW

COMPETITIVE ANALYSIS

MARKET TRENDS

MARKET DEVELOPMENTS

PROCEDURE NUMBERS

MARKETS INCLUDED

VERSION HISTORY

RESEARCH METHODOLOGY

  • Step 1: Project Initiation & Team Selection
  • Step 2: Prepare Data Systems and Perform Secondary Research
  • Step 3: Preparation for Interviews & Questionnaire Design
  • Step 4: Performing Primary Research
  • Step 5: Research Analysis: Establishing Baseline Estimates
  • Step 6: Market Forecast and Analysis
  • Step 7: Identify Strategic Opportunities
  • Step 8: Final Review and Market Release
  • Step 9: Customer Feedback and Market Monitoring

DISEASE OVERVIEW

  • 2.1. BASIC ANATOMY
  • 2.2. DISEASE TREATMENTS & DIAGNOSTICS
    • 2.2.1. Aortic Aneurysms
    • 2.2.2. Atherosclerosis
    • 2.2.3. Peripheral Arterial Disease (PAD)
    • 2.2.4. Deep Vein Thrombosis (DVT)
    • 2.2.5. Pulmonary Embolism (PE)
  • 2.3. PATIENT DEMOGRAPHICS
    • 2.3.1. Aortic Aneurysms
    • 2.3.2. Atherosclerosis
    • 2.3.3. Peripheral Arterial Disease (PAD)
    • 2.3.4. Deep Vein Thrombosis (DVT)
    • 2.3.5. Pulmonary Embolism (PE)

PRODUCT ASSESSMENT

  • 3.1. INTRODUCTION
  • 3.2. PRODUCT PORTFOLIOS
    • 3.2.1. Peripheral Vascular Stent
    • 3.2.2. Venous Stent
    • 3.2.3. Percutaneous Transluminal Angioplasty (PTA) Balloon
    • 3.2.4. Drug-Coated Balloon
    • 3.2.5. Atherectomy Device
    • 3.2.6. Chronic Total Occlusion (CTO) Device
    • 3.2.7. Intravascular Lithotripsy
    • 3.2.8. Surgical Graft
    • 3.2.9. Stent Graft
    • 3.2.10. Embolic Protection Device
    • 3.2.11. Peripheral Thrombus Management Device
    • 3.2.12. Inferior Vena Cava Filter
    • 3.2.13. Carotid Shunt
    • 3.2.14. Diagnostic and Interventional Catheters
    • 3.2.15. Diagnostic and Interventional Guidewire
    • 3.2.16. Introducer Sheath
    • 3.2.17. Vascular Closure Device (VCD)
    • 3.2.18. Transcatheter Embolization Device
    • 3.2.19. Peripheral IVUS Catheter
  • 3.3. REGULATORY ISSUES AND RECALLS
  • 3.4. CLINICAL TRIALS
    • 3.4.1. Abbott
      • 3.4.1.1. Peripheral Vascular Stent
      • 3.4.1.2. Other Peripheral Vascular Related Studies
    • 3.4.2. B. Braun
      • 3.4.2.1. Diagnostic and Interventional Catheters
      • 3.4.2.2. Peripheral Vascular Stent
    • 3.4.3. Boston Scientific
      • 3.4.3.1. Atherectomy Devices
      • 3.4.3.2. Drug-Coated Balloons
      • 3.4.3.3. Peripheral Vascular Stents
      • 3.4.3.4. Other Peripheral Vascular Related Studies
      • 3.4.3.5. Venous Stents
    • 3.4.4. C.R. Bard (BD)
      • 3.4.4.1. Diagnostic and Interventional Catheters
      • 3.4.4.2. Drug-Coated Balloons
      • 3.4.4.3. Venous Stents
      • 3.4.4.4. Other Peripheral Vascular Related Studies
    • 3.4.5. Cardinal Health
      • 3.4.5.1. Other Peripheral Vascular Related Studies
    • 3.4.6. Cook Medical
      • 3.4.6.1. Drug-Eluting Stents
      • 3.4.6.2. Inferior Vena Cava Filters
      • 3.4.6.3. Peripheral Vascular Stents
      • 3.4.6.4. Venous Stents
    • 3.4.7. Cordis (Cardinal Health)
      • 3.4.7.1. Peripheral Vascular Stents
    • 3.4.8. Medtronic
      • 3.4.8.1. Atherectomy Devices
      • 3.4.8.2. Drug-Coated Balloons
      • 3.4.8.3. Other Peripheral Vascular Related Studies
    • 3.4.10. Shockwave Medical, Inc.
      • 3.4.10.1. Lithoplasty System
    • 3.4.11. Surmodics
      • 3.4.11.1. Drug-Coated Balloons
    • 3.4.12. Terumo
      • 3.4.12.1. Drug-Coated Balloons
      • 3.4.12.2. Peripheral Vascular Stents
    • 3.4.13. W.L. Gore
      • 3.4.13.1. Peripheral Vascular Stents
      • 3.4.13.2. Stent Grafts
      • 3.4.13.3. Expandable Balloons
    • 3.4.14. Other Companies
      • 3.4.14.1. Carotid Shunt / Endarterectomy
      • 3.4.14.2. Drug-Coated Balloons
      • 3.4.14.3. Peripheral Vascular Stents
      • 3.4.14.4. Other Peripheral Vascular Related Studies

GLOBAL PERIPHERAL VASCULAR DEVICE MARKET OVERVIEW

  • 4.1. INTRODUCTION
    • 4.1.1. Atherosclerosis
    • 4.1.2. Peripheral Arterial Disease (PAD)
  • 4.2. MARKET OVERVIEW
  • 4.3. TREND ANALYSIS BY REGION
    • 4.3.1. Global Trends
    • 4.3.2. North America
    • 4.3.3. Latin America
    • 4.3.4. Western Europe
    • 4.3.5. Central and Eastern Europe
    • 4.3.6. Middle East
    • 4.3.7. Africa
    • 4.3.8. Asia-Pacific
  • 4.4. DRIVERS AND LIMITERS
    • 4.4.1. Market Drivers
    • 4.4.2. Market Limiters
  • 4.5. COMPETITIVE MARKET SHARE ANALYSIS
  • 4.6. MERGERS AND ACQUISITIONS
  • 4.7. COMPANY PROFILES
    • 4.7.1. Abbott
    • 4.7.2. Becton Dickinson (BD)
    • 4.7.3. Boston Scientific
    • 4.7.4. Cardinal Health
      • 4.7.4.1. Cordis (Cardinal Health)
    • 4.7.5. Cook Medical
    • 4.7.6. Maquet
    • 4.7.7. Medtronic
    • 4.7.8. Teleflex
    • 4.7.9. Terumo Interventional System (TIS)
    • 4.7.10. W.L. Gore
  • 4.8. SWOT ANALYSIS
    • 4.8.1. Abbott
    • 4.8.2. B. Braun
    • 4.8.3. Boston Scientific
    • 4.8.4. BD
    • 4.8.5. Cardinal Health
    • 4.8.6. Cook Medical
    • 4.8.7. Integra Lifesciences
    • 4.8.8. Maquet
    • 4.8.9. Medtronic
    • 4.8.10. Merit Medical
    • 4.8.11. Phillips
    • 4.8.12. Teleflex
    • 4.8.13. Terumo
    • 4.8.14. W.L. Gore

PROCEDURE NUMBERS

  • 5.1. INTRODUCTION
  • 5.2. PROCEDURES
    • 5.2.1. Global Procedures
      • 5.2.1.1. Bare Metal Stent Procedures by Indication
      • 5.2.1.2. Stent Graft Procedures by Indication
      • 5.2.1.3. Surgical Graft Procedures by Indication
    • 5.2.2. North America Procedures
      • 5.2.2.1. Bare-Metal Stent Procedures by Indication
      • 5.2.2.2. Stent Graft Procedures by Indication
      • 5.2.2.3. Surgical Graft Procedures by Indication
    • 5.2.3. Latin America Procedures
      • 5.2.3.1. Bare-Metal Stent Procedures by Indication
      • 5.2.3.2. Stent Graft Procedures by Indication
      • 5.2.3.3. Surgical Graft Procedures by Indication
    • 5.2.4. Western Europe Procedures
      • 5.2.4.1. Bare-Metal Stent Procedures
      • 5.2.4.2. Stent Graft Procedures by Indication
      • 5.2.4.3. Surgical Graft Procedures by Indication
    • 5.2.5. Central & Eastern Europe Procedures
      • 5.2.5.1. Bare-Metal Stent Procedures by Indication
      • 5.2.5.2. Stent Graft Procedures by Indication
      • 5.2.5.3. Surgical Graft Procedures by Indication
    • 5.2.6. Middle East Procedures
      • 5.2.6.1. Bare-Metal Stent Procedures by Indication
      • 5.2.6.2. Stent Graft Procedures by Indication
      • 5.2.6.3. Surgical Procedures by Indication
    • 5.2.7. Africa Procedures
      • 5.2.7.1. Bare-Metal Stent Procedures by Indication
      • 5.2.7.2. Stent Graft Procedures by Indication
      • 5.2.7.3. Surgical Graft Procedures by Indication
    • 5.2.8. Asia-Pacific Procedures
      • 5.2.8.1. Bare-Metal Stent Procedures by Indication
      • 5.2.8.2. Stent Graft Procedures by Indication
      • 5.2.8.3. Surgical Graft Procedures by Indication

NORTH AMERICA MARKET

  • 6.1. INTRODUCTION
    • 6.1.1. Countries Included
  • 6.2. MARKET OVERVIEW
  • 6.3. MARKET ANALYSIS AND FORECAST
    • 6.3.1. Peripheral Vascular Stent Market
      • 6.3.1.1. Market Overview
      • 6.3.1.2. Total Peripheral Vascular Stent Market
        • 6.3.1.2.1. Total Bare-Metal Stent Market
        • 6.3.1.2.2. Covered Stent Market
        • 6.3.1.2.3. Drug-Eluting Stent Market
    • 6.3.2. PTA Balloon Catheter Market
    • 6.3.3. Drug-Coated Balloon Market
    • 6.3.4. Atherectomy Disposables Market
    • 6.3.5. CTO Device Market
    • 6.3.6. Stent Graft Market
      • 6.3.6.1. Market Overview
      • 6.3.6.2. Total Stent Graft Market
    • 6.3.7. Surgical Graft Market
      • 6.3.7.1. Market Overview
      • 6.3.7.2. Total Surgical Graft Market
        • 6.3.7.2.1. Total Aorta Repair Surgical Graft Market
        • 6.3.7.2.2. Lower Limb Surgical Graft Market
        • 6.3.7.2.3. Extra-Anatomical Surgical Graft Market
    • 6.3.8. Diagnostic & Interventional Guidewire Market
      • 6.3.8.1. Market Overview
      • 6.3.8.2. Total Diagnostic & Interventional Guidewire Market
        • 6.3.8.2.1. Standard Guidewire Market
        • 6.3.8.2.2. Hydrophilic Guidewire Market
    • 6.3.9. Diagnostic & Interventional Catheter Market
      • 6.3.9.1. Market Overview
      • 6.3.9.2. Total Diagnostic & Interventional Catheter Market
        • 6.3.9.2.1. Diagnostic Catheter Market
        • 6.3.9.2.2. Interventional Catheter Market
    • 6.3.10. Introducer Sheath Market
    • 6.3.11. Vascular Closure Device Market
      • 6.3.11.1. Market Overview
      • 6.3.11.2. Total VCD Market
        • 6.3.11.2.1. Invasive VCD Market
        • 6.3.11.2.2. Non-Invasive VCD Market
    • 6.3.12. Peripheral IVUS Catheter Market

LATIN AMERICA MARKET

  • 7.1. INTRODUCTION
    • 7.1.1. Countries Included
  • 7.2. MARKET OVERVIEW
  • 7.3. MARKET ANALYSIS AND FORECAST
    • 7.3.1. Peripheral Vascular Stent Market
      • 7.3.1.1. Market Overview
      • 7.3.1.2. Total Peripheral Vascular Stent Market
        • 7.3.1.2.1. Total Bare-Metal Stent Market
        • 7.3.1.2.2. Covered Stent Market
        • 7.3.1.2.3. Drug-Eluting Stent Market
    • 7.3.2. PTA Balloon Catheter Market
    • 7.3.3. Drug-Coated Balloon Market
    • 7.3.4. Atherectomy Disposables Market
    • 7.3.5. CTO Device Market
    • 7.3.6. Stent Graft Market
      • 7.3.6.1. Market Overview
      • 7.3.6.2. Total Stent Graft Market
        • 7.3.6.2.1. AAA Stent Graft Market
        • 7.3.6.2.2. TAA Stent Graft Market
        • 7.3.6.2.3. FAA Stent Graft Market
    • 7.3.7. Surgical Graft Market
      • 7.3.7.1. Market Overview
      • 7.3.7.2. Total Surgical Graft Market
        • 7.3.7.2.1. Total Aorta Repair Surgical Graft Market
        • 7.3.7.2.2. Lower Limb Surgical Graft Market
        • 7.3.7.2.3. Extra-Anatomical Surgical Graft Market
    • 7.3.8. Diagnostic & Interventional Guidewire Market
      • 7.3.8.1. Market Overview
      • 7.3.8.2. Total Diagnostic & Interventional Guidewire Market
        • 7.3.8.2.1. Standard Guidewire Market
        • 7.3.8.2.2. Hydrophilic Guidewire Market
    • 7.3.9. Diagnostic & Interventional Catheter Market
      • 7.3.9.1. Market Overview
      • 7.3.9.2. Total Diagnostic & Interventional Catheter Market
        • 7.3.9.2.1. Diagnostic Catheter Market
        • 7.3.9.2.2. Interventional Catheter Market
    • 7.3.10. Introducer Sheath Market
    • 7.3.11. Vascular Closure Device Market
      • 7.3.11.1. Market Overview
      • 7.3.11.2. Total VCD Market
        • 7.3.11.2.1. Invasive VCD Market
        • 7.3.11.2.2. Non-Invasive VCD Market
    • 7.3.12. Peripheral IVUS Catheter Market

WESTERN EUROPE MARKET

  • 8.1. INTRODUCTION
    • 8.1.1. Countries Included
  • 8.2. MARKET OVERVIEW
  • 8.3. MARKET ANALYSIS AND FORECAST
    • 8.3.1. Peripheral Vascular Stent Market
      • 8.3.1.1. Market Overview
      • 8.3.1.2. Total Peripheral Vascular Stent Market
        • 8.3.1.2.1. Total Bare-Metal Stent Market
        • 8.3.1.2.2. Covered Stent Market
        • 8.3.1.2.3. Drug-Eluting Stent Market
    • 8.3.2. PTA Balloon Catheter Market
    • 8.3.3. Drug-Coated Balloon Market
    • 8.3.4. Atherectomy Disposables Market
    • 8.3.5. CTO Device Market
    • 8.3.6. Stent Graft Market
      • 8.3.6.1. Market Overview
      • 8.3.6.2. Total Stent Graft Market
        • 8.3.6.2.1. AAA Stent Graft Market
        • 8.3.6.2.2. TAA Stent Graft Market
        • 8.3.6.2.3. FAA Stent Graft Market
    • 8.3.7. Surgical Graft Market
      • 8.3.7.1. Market Overview
      • 8.3.7.2. Total Surgical Graft Market
        • 8.3.7.2.1. Total Aorta Repair Surgical Graft Market
        • 8.3.7.2.2. Lower Limb Surgical Graft Market
        • 8.3.7.2.3. Extra-Anatomical Surgical Graft Market
    • 8.3.8. Diagnostic & Interventional Guidewire Market
      • 8.3.8.1. Market Overview
      • 8.3.8.2. Total Diagnostic & Interventional Guidewire Market
        • 8.3.8.2.1. Standard Guidewire Market
        • 8.3.8.2.2. Hydrophilic Guidewire Market
    • 8.3.9. Diagnostic & Interventional Catheter Market
      • 8.3.9.1. Market Overview
      • 8.3.9.2. Total Diagnostic & Interventional Catheter Market
        • 8.3.9.2.1. Diagnostic Catheter Market
        • 8.3.9.2.2. Interventional Catheter Market
    • 8.3.10. Introducer Sheath Market
    • 8.3.11. Vascular Closure Device Market
      • 8.3.11.1. Market Overview
      • 8.3.11.2. Total VCD Market
        • 8.3.11.2.1. Invasive VCD Market
        • 8.3.11.2.2. Non-Invasive VCD Market
    • 8.3.12. Peripheral IVUS Catheter Market

CENTRAL & EASTERN EUROPE MARKET

  • 9.1. INTRODUCTION
    • 9.1.1. Countries Included
  • 9.2. MARKET OVERVIEW
  • 9.3. MARKET ANALYSIS AND FORECAST
    • 9.3.1. Peripheral Vascular Stent Market
      • 9.3.1.1. Market Overview
      • 9.3.1.2. Total Peripheral Vascular Stent Market
        • 9.3.1.2.1. Total Bare-Metal Stent Market
        • 9.3.1.2.2. Covered Stent Market
        • 9.3.1.2.3. Drug-Eluting Stent Market
    • 9.3.2. PTA Balloon Catheter Market
    • 9.3.3. Drug-Coated Balloon Market
    • 9.3.4. Atherectomy Disposables Market
    • 9.3.5. CTO Device Market
    • 9.3.6. Stent Graft Market
      • 9.3.6.1. Market Overview
      • 9.3.6.2. Total Stent Graft Market
        • 9.3.6.2.1. AAA Stent Graft Market
        • 9.3.6.2.2. TAA Stent Graft Market
        • 9.3.6.2.3. FAA Stent Graft Market
    • 9.3.7. Surgical Graft Market
      • 9.3.7.1. Market Overview
      • 9.3.7.2. Total Surgical Graft Market
        • 9.3.7.2.1. Total Aorta Repair Surgical Graft Market
        • 9.3.7.2.2. Lower Limb Surgical Graft Market
        • 9.3.7.2.3. Extra-Anatomical Surgical Graft Market
    • 9.3.8. Diagnostic & Interventional Guidewire Market
      • 9.3.8.1. Market Overview
      • 9.3.8.2. Total Diagnostic & Interventional Guidewire Market
        • 9.3.8.2.1. Standard Guidewire Market
        • 9.3.8.2.2. Hydrophilic Guidewire Market
    • 9.3.9. Diagnostic & Interventional Catheter Market
      • 9.3.9.1. Market Overview
      • 9.3.9.2. Total Diagnostic & Interventional Catheter Market
        • 9.3.9.2.1. Diagnostic Catheter Market
        • 9.3.9.2.2. Interventional Catheter Market
    • 9.3.10. Introducer Sheath Market
    • 9.3.11. Vascular Closure Device Market
      • 9.3.11.1. Market Overview
      • 9.3.11.2. Total VCD Market
        • 9.3.11.2.1. Invasive VCD Market
        • 9.3.11.2.2. Non-Invasive VCD Market
    • 9.3.12. Peripheral IVUS Catheter Market

MIDDLE EAST MARKET

  • 10.1. INTRODUCTION
    • 10.1.1. Countries Included
  • 10.2. MARKET OVERVIEW
  • 10.3. MARKET ANALYSIS AND FORECAST
    • 10.3.1. Peripheral Vascular Stent Market
      • 10.3.1.1. Market Overview
      • 10.3.1.2. Total Peripheral Vascular Stent Market
        • 10.3.1.2.1. Total Bare-Metal Stent Market
        • 10.3.1.2.2. Covered Stent Market
        • 10.3.1.2.3. Drug-Eluting Stent Market
    • 10.3.2. PTA Balloon Catheter Market
    • 10.3.3. Drug-Coated Balloon Market
    • 10.3.4. Atherectomy Disposables Market
    • 10.3.5. CTO Device Market
    • 10.3.6. Stent Graft Market
      • 10.3.6.1. Market Overview
      • 10.3.6.2. Total Stent Graft Market
        • 10.3.6.2.1. AAA Stent Graft Market
        • 10.3.6.2.2. TAA Stent Graft Market
        • 10.3.6.2.3. FAA Stent Graft Market
    • 10.3.7. Surgical Graft Market
      • 10.3.7.1. Market Overview
      • 10.3.7.2. Total Surgical Graft Market
        • 10.3.7.2.1. Total Aorta Repair Surgical Graft Market
        • 10.3.7.2.2. Lower Limb Surgical Graft Market
        • 10.3.7.2.3. Extra-Anatomical Surgical Graft Market
    • 10.3.8. Diagnostic & Interventional Guidewire Market
      • 10.3.8.1. Market Overview
      • 10.3.8.2. Total Diagnostic & Interventional Guidewire Market
        • 10.3.8.2.1. Standard Guidewire Market
        • 10.3.8.2.2. Hydrophilic Guidewire Market
    • 10.3.9. Diagnostic & Interventional Catheter Market
      • 10.3.9.1. Market Overview
      • 10.3.9.2. Total Diagnostic & Interventional Catheter Market
        • 10.3.9.2.1. Diagnostic Catheter Market
        • 10.3.9.2.2. Interventional Catheter Market
    • 10.3.10. Introducer Sheath Market
    • 10.3.11. Vascular Closure Device Market
      • 10.3.11.1. Market Overview
      • 10.3.11.2. Total VCD Market
        • 10.3.11.2.1. Invasive VCD Market
        • 10.3.11.2.2. Non-Invasive VCD Market
    • 10.3.12. Peripheral IVUS Catheter Market

AFRICA MARKET

  • 11.1. INTRODUCTION
    • 11.1.1. Countries Included
  • 11.2. MARKET OVERVIEW
  • 11.3. MARKET ANALYSIS AND FORECAST
    • 11.3.1. Peripheral Vascular Stent Market
      • 11.3.1.1. Market Overview
      • 11.3.1.2. Total Peripheral Vascular Stent Market
        • 11.3.1.2.1. Total Bare-Metal Stent Market
        • 11.3.1.2.2. Covered Stent Market
        • 11.3.1.2.3. Drug-Eluting Stent Market
    • 11.3.2. PTA Balloon Catheter Market
    • 11.3.3. Drug-Coated Balloon Market
    • 11.3.4. Atherectomy Disposables Market
    • 11.3.5. CTO Device Market
    • 11.3.6. Stent Graft Market
      • 11.3.6.1. Market Overview
      • 11.3.6.2. Total Stent Graft Market
        • 11.3.6.2.1. AAA Stent Graft Market
        • 11.3.6.2.2. TAA Stent Graft Market
        • 11.3.6.2.3. FAA Stent Graft Market
    • 11.3.7. Surgical Graft Market
      • 11.3.7.1. Market Overview
      • 11.3.7.2. Total Surgical Graft Market
        • 11.3.7.2.1. Total Aorta Repair Surgical Graft Market
        • 11.3.7.2.2. Lower Limb Surgical Graft Market
        • 11.3.7.2.3. Extra-Anatomical Surgical Graft Market
    • 11.3.8. Diagnostic & Interventional Guidewire Market
      • 11.3.8.1. Market Overview
      • 11.3.8.2. Total Diagnostic & Interventional Guidewire Market
        • 11.3.8.2.1. Standard Guidewire Market
        • 11.3.8.2.2. Hydrophilic Guidewire Market
    • 11.3.9. Diagnostic & Interventional Catheter Market
      • 11.3.9.1. Market Overview
      • 11.3.9.2. Total Diagnostic & Interventional Catheter Market
        • 11.3.9.2.1. Diagnostic Catheter Market
        • 11.3.9.2.2. Interventional Catheter Market
    • 11.3.10. Introducer Sheath Market
    • 11.3.11. Vascular Closure Device Market
      • 11.3.11.1. Market Overview
      • 11.3.11.2. Total VCD Market
        • 11.3.11.2.1. Invasive VCD Market
        • 11.3.11.2.2. Non-Invasive VCD Market
    • 11.3.12. Peripheral IVUS Catheter Market

ASIA-PACIFIC MARKET

  • 12.1. INTRODUCTION
    • 12.1.1. Countries Included
  • 12.2. MARKET OVERVIEW
  • 12.3. MARKET ANALYSIS AND FORECAST
    • 12.3.1. Peripheral Vascular Stent Market
      • 12.3.1.1. Market Overview
      • 12.3.1.2. Total Peripheral Vascular Stent Market
        • 12.3.1.2.1. Total Bare-Metal Stent Market
        • 12.3.1.2.2. Covered Stent Market
        • 12.3.1.2.3. Drug-Eluting Stent Market
    • 12.3.2. PTA Balloon Catheter Market
    • 12.3.3. Drug-Coated Balloon Market
    • 12.3.4. Atherectomy Disposables Market
    • 12.3.5. CTO Device Market
    • 12.3.6. Stent Graft Market
      • 12.3.6.1. Market Overview
      • 12.3.6.2. Total Stent Graft Market
        • 12.3.6.2.1. AAA Stent Graft Market
        • 12.3.6.2.2. TAA Stent Graft Market
        • 12.3.6.2.3. FAA Stent Graft Market
    • 12.3.7. Surgical Graft Market
      • 12.3.7.1. Market Overview
      • 12.3.7.2. Total Surgical Graft Market
        • 12.3.7.2.1. Total Aorta Repair Surgical Graft Market
        • 12.3.7.2.2. Lower Limb Surgical Graft Market
        • 12.3.7.2.3. Extra-Anatomical Surgical Graft Market
    • 12.3.8. Diagnostic & Interventional Guidewire Market
      • 12.3.8.1. Market Overview
      • 12.3.8.2. Total Diagnostic & Interventional Guidewire Market
        • 12.3.8.2.1. Standard Guidewire Market
        • 12.3.8.2.2. Hydrophilic Guidewire Market
    • 12.3.9. Diagnostic & Interventional Catheter Market
      • 12.3.9.1. Market Overview
      • 12.3.9.2. Total Diagnostic & Interventional Catheter Market
        • 12.3.9.2.1. Diagnostic Catheter Market
        • 12.3.9.2.2. Interventional Catheter Market
    • 12.3.10. Introducer Sheath Market
    • 12.3.11. Vascular Closure Device Market
      • 12.3.11.1. Market Overview
      • 12.3.11.2. Total VCD Market
        • 12.3.11.2.1. Invasive VCD Market
        • 12.3.11.2.2. Non-Invasive VCD Market
    • 12.3.12. Peripheral IVUS Catheter Market

APPENDIX: GLOBAL LITHOTRIPSY MARKET

  • 13.1. INTRODUCTION
  • 13.2. PROCEDURES
    • 13.2.1. Global Procedures
  • 13.3. MARKET OVERVIEW
  • 13.4. MARKET ANALYSIS AND FORECAST
    • 13.4.1. Global Lithotripsy Market
      • 13.4.1.1. U.S. Lithotripsy Market
      • 13.4.1.2. Western Europe Lithotripsy Market
      • 13.4.1.3. Rest of the World Lithotripsy Market

ABBREVIATIONS

LIST OF CHARTS

  • Chart 1 1: Peripheral Vascular Device Market by Segment, Global, 2016 - 2026
  • Chart 1 2: Peripheral Vascular Device Market Overview, Global, 2019 & 2026
  • Chart 4 1: Peripheral Vascular Device Market by Segment, Global, 2016 - 2026
  • Chart 4 2: Peripheral Vascular Device Market Breakdown, Global, 2019
  • Chart 4 3: Peripheral Vascular Device Market Breakdown, Global, 2026
  • Chart 4 4: Growth Rates by Segment, Peripheral Vascular Device Market, Global, 2017 - 2026
  • Chart 4 5: Leading Competitors, Peripheral Vascular Device Market, Global, 2019
  • Chart 5 1: Procedures by Segment, Global, 2016 - 2026
  • Chart 5 2: Bare-Metal Stent Procedures by Indication, Global, 2016 - 2026
  • Chart 5 3: Stent Graft Procedures by Indication, Global, 2016 - 2026
  • Chart 5 4: Surgical Graft Procedures by Indication, Global, 2016 - 2026
  • Chart 5 5: Procedures by Segment, North America, 2016 - 2026
  • Chart 5 6: Bare-Metal Stent Procedures by Indication, North America, 2016 - 2026
  • Chart 5 7: Stent Graft Procedures by Indication, North America, 2016 - 2026
  • Chart 5 8: Surgical Graft Procedures by Indication, North America, 2016 - 2026
  • Chart 5 9: Procedures by Segment, Latin America, 2016 - 2026
  • Chart 5 10: Bare-Metal Stent Procedures by Indication, Latin America, 2016 - 2026
  • Chart 5 11: Stent Graft Procedures by Indication, Latin America, 2016 - 2026
  • Chart 5 12: Surgical Graft Procedures by Indication, Latin America, 2016 - 2026
  • Chart 5 13: Procedures by Segment, Western Europe, 2016 - 2026
  • Chart 5 14: Bare-Metal Stent Procedures by Indication, Western Europe, 2016 - 2026
  • Chart 5 15: Stent Graft Procedures by Indication, Western Europe, 2016 - 2026
  • Chart 5 16: Surgical Graft Procedures by Indication, Western Europe, 2016 - 2026
  • Chart 5 17: Procedures by Segment, Central & Eastern Europe, 2016 - 2026
  • Chart 5 18: Bare-Metal Stent Procedures by Indication, Central & Eastern Europe, 2016 - 2026
  • Chart 5 19: Stent Graft Procedures by Indication, Central & Eastern Europe, 2016 - 2026
  • Chart 5 20: Surgical Graft Procedures by Indication, Central & Eastern Europe, 2016 - 2026
  • Chart 5 21: Procedures by Segment, Middle East, 2016 - 2026
  • Chart 5 22: Bare-Metal Stent Procedures by Indication, Middle East, 2016 - 2026
  • Chart 5 23: Stent Graft Procedures by Indication, Middle East, 2016 - 2026
  • Chart 5 24: Surgical Graft Procedures by Indication, Middle East, 2016 - 2026
  • Chart 5 25: Procedures by Segment, Africa, 2016 - 2026
  • Chart 5 26: Bare-Metal Stent Procedures by Indication, Africa, 2016 - 2026
  • Chart 5 27: Stent Graft Procedures by Indication, Africa, 2016 - 2026
  • Chart 5 28: Surgical Graft Procedures by Indication, Africa, 2016 - 2026
  • Chart 5 29: Procedures by Segment, Asia-Pacific, 2016 - 2026
  • Chart 5 30: Bare-Metal Stent Procedures by Indication, Asia-Pacific, 2016 - 2026
  • Chart 5 31: Stent Graft Procedures by Indication, Asia-Pacific, 2016 - 2026
  • Chart 5 32: Surgical Graft Procedures by Indication, Asia-Pacific, 2016 - 2026
  • Chart 6 1: Peripheral Vascular Device Market by Segment, North America, 2016 - 2026
  • Chart 6 2: Peripheral Vascular Device Market by Segment, North America, 2019
  • Chart 6 3: Peripheral Vascular Device Market by Segment, North America, 2026
  • Chart 6 4: Peripheral Vascular Stent Market by Segment, North America, 2016 - 2026
  • Chart 6 5: PTA Balloon Catheter Market, North America, 2016 - 2026
  • Chart 6 6: Drug Coated Balloon Market, North America, 2016 - 2026
  • Chart 6 7: Atherectomy Disposables Market, North America, 2016 - 2026
  • Chart 6 8: CTO Device Market, North America, 2016 - 2026
  • Chart 6 9: Stent Graft Market by Segment, North America, 2016 - 2026
  • Chart 6 10: Surgical Graft Market by Segment, North America, 2016 - 2026
  • Chart 6 11: Diagnostic & Interventional Guidewire Market by Segment, North America, 2016 - 2026
  • Chart 6 12: Diagnostic & Interventional Catheter Market by Segment, North America, 2016 - 2026
  • Chart 6 13: Introducer Sheath Market, North America, 2016 - 2026
  • Chart 6 14: VCD Market by Segment, North America, 2016 - 2026
  • Chart 6 15: Peripheral IVUS Catheter Market, North America, 2016 - 2026
  • Chart 7 1: Peripheral Vascular Device Market by Segment, Latin America, 2016 - 2026
  • Chart 7 2: Peripheral Vascular Device Market by Segment, Latin America, 2019
  • Chart 7 3: Peripheral Vascular Device Market by Segment, Latin America, 2026
  • Chart 7 4: Peripheral Vascular Stent Market by Segment, Latin America, 2016 - 2026
  • Chart 7 5: PTA Balloon Catheter Market, Latin America, 2016 - 2026
  • Chart 7 6: Drug Coated Balloon Market, Latin America, 2016 - 2026
  • Chart 7 7: Atherectomy Disposables Market, Latin America, 2016 - 2026
  • Chart 7 8: CTO Device Market, Latin America, 2016 - 2026
  • Chart 7 9: Stent Graft Market by Segment, Latin America, 2016 - 2026
  • Chart 7 10: Surgical Graft Market by Segment, Latin America, 2016 - 2026
  • Chart 7 11: Diagnostic & Interventional Guidewire Market by Segment, Latin America, 2016 - 2026
  • Chart 7 12: Diagnostic & Interventional Catheter Market by Segment, Latin America, 2016 - 2026
  • Chart 7 13: Introducer Sheath Market, Latin America, 2016 - 2026
  • Chart 7 14: VCD Market by Segment, Latin America, 2016 - 2026
  • Chart 7 15: Peripheral IVUS Catheter Market, Latin America, 2016 - 2026
  • Chart 8 1: Peripheral Vascular Device Market by Segment, Western Europe, 2016 - 2026
  • Chart 8 2: Peripheral Vascular Device Market by Segment, Western Europe, 2019
  • Chart 8 3: Peripheral Vascular Device Market by Segment, Western Europe, 2026
  • Chart 8 4: Peripheral Vascular Stent Market by Segment, Western Europe, 2016 - 2026
  • Chart 8 5: PTA Balloon Catheter Market, Western Europe, 2016 - 2026
  • Chart 8 6: Drug Coated Balloon Market, Western Europe, 2016 - 2026
  • Chart 8 7: Atherectomy Disposables Market, Western Europe, 2016 - 2026
  • Chart 8 8: CTO Device Market, Western Europe, 2016 - 2026
  • Chart 8 9: Stent Graft Market by Segment, Western Europe, 2016 - 2026
  • Chart 8 10: Surgical Graft Market by Segment, Western Europe, 2016 - 2026
  • Chart 8 11: Diagnostic & Interventional Guidewire Market by Segment, Western Europe, 2016 - 2026
  • Chart 8 12: Diagnostic & Interventional Catheter Market by Segment, Western Europe, 2016 - 2026
  • Chart 8 13: Introducer Sheath Market, Western Europe, 2016 - 2026
  • Chart 8 14: VCD Market by Segment, Western Europe, 2016 - 2026
  • Chart 8 15: Peripheral IVUS Catheter Market, Western Europe, 2016 - 2026
  • Chart 9 1: Peripheral Vascular Device Market by Segment, Central & Eastern Europe, 2016 - 2026
  • Chart 9 2: Peripheral Vascular Device Market by Segment, Central & Eastern Europe, 2019
  • Chart 9 3: Peripheral Vascular Device Market by Segment, Central & Eastern Europe, 2026
  • Chart 9 4: Peripheral Vascular Stent Market by Segment, Central & Eastern Europe, 2016 - 2026
  • Chart 9 5: PTA Balloon Catheter Market, Central & Eastern Europe, 2016 - 2026
  • Chart 9 6: Drug Coated Balloon Market, Central & Eastern Europe, 2016 - 2026
  • Chart 9 7: Atherectomy Disposables Market, Central & Eastern Europe, 2016 - 2026
  • Chart 9 8: CTO Device Market, Central & Eastern Europe, 2016 - 2026
  • Chart 9 9: Stent Graft Market by Segment, Central & Eastern Europe, 2016 - 2026
  • Chart 9 10: Surgical Graft Market by Segment, Central & Eastern Europe, 2016 - 2026
  • Chart 9 11: Diagnostic & Interventional Guidewire Market by Segment, Central & Eastern Europe, 2016 - 2026
  • Chart 9 12: Diagnostic & Interventional Catheter Market by Segment, Central & Eastern Europe, 2016 - 2026
  • Chart 9 13: Introducer Sheath Market, Central & Eastern Europe, 2016 - 2026
  • Chart 9 14: VCD Market by Segment, Central & Eastern Europe, 2016 - 2026
  • Chart 9 15: Peripheral IVUS Catheter Market, Central & Eastern Europe, 2016 - 2026
  • Chart 10 1: Peripheral Vascular Device Market by Segment, Middle East, 2016 - 2026
  • Chart 10 2: Peripheral Vascular Device Market by Segment, Middle East, 2019
  • Chart 10 3: Peripheral Vascular Device Market by Segment, Middle East, 2026
  • Chart 10 4: Peripheral Vascular Stent Market by Segment, Middle East, 2016 - 2026
  • Chart 10 5: PTA Balloon Catheter Market, Middle East, 2016 - 2026
  • Chart 10 6: Drug-Coated Balloon Market, Middle East, 2016 - 2026
  • Chart 10 7: Atherectomy Disposables Market, Middle East, 2016 - 2026
  • Chart 10 8: CTO Device Market, Middle East, 2016 - 2026
  • Chart 10 9: Stent Graft Market by Segment, Middle East, 2016 - 2026
  • Chart 10 10: Surgical Graft Market by Segment, Middle East, 2016 - 2026
  • Chart 10 11: Diagnostic & Interventional Guidewire Market by Segment, Middle East, 2016 - 2026
  • Chart 10 12: Diagnostic & Interventional Catheter Market by Segment, Middle East, 2016 - 2026
  • Chart 10 13: Introducer Sheath Market, Middle East, 2016 - 2026
  • Chart 10 14: VCD Market by Segment, Middle East, 2016 - 2026
  • Chart 10 15: Peripheral IVUS Catheter Market, Middle East, 2016 - 2026
  • Chart 11 1: Peripheral Vascular Device Market by Segment, Africa, 2016 - 2026
  • Chart 11 2: Peripheral Vascular Device Market by Segment, Africa, 2019
  • Chart 11 3: Peripheral Vascular Device Market by Segment, Africa, 2026
  • Chart 11 4: Peripheral Vascular Stent Market by Segment, Africa, 2016 - 2026
  • Chart 11 5: PTA Balloon Catheter Market, Africa, 2016 - 2026
  • Chart 11 6: Drug-Coated Balloon Market, Africa, 2016 - 2026
  • Chart 11 7: Atherectomy Disposables Market, Africa, 2016 - 2026
  • Chart 11 8: CTO Device Market, Africa, 2016 - 2026
  • Chart 11 9: Stent Graft Market by Segment, Africa, 2016 - 2026
  • Chart 11 10: Surgical Graft Market by Segment, Africa, 2016 - 2026
  • Chart 11 11: Diagnostic & Interventional Guidewire Market by Segment, Africa, 2016 - 2026
  • Chart 11 12: Diagnostic & Interventional Catheter Market by Segment, Africa, 2016 - 2026
  • Chart 11 13: Introducer Sheath Market, Africa, 2016 - 2026
  • Chart 11 14: VCD Market by Segment, Africa, 2016 - 2026
  • Chart 11 15: Peripheral IVUS Catheter Market, Africa, 2016 - 2026
  • Chart 12 1: Peripheral Vascular Device Market by Segment, Asia-Pacific, 2016 - 2026
  • Chart 12 2: Peripheral Vascular Device Market by Segment, Asia-Pacific, 2019
  • Chart 12 3: Peripheral Vascular Device Market by Segment, Asia-Pacific, 2026
  • Chart 12 4: Peripheral Vascular Stent Market by Segment, Asia-Pacific, 2016 - 2026
  • Chart 12 5: PTA Balloon Catheter Market, Asia-Pacific, 2016 - 2026
  • Chart 12 6: Drug-Coated Balloon Market, Asia-Pacific, 2016 - 2026
  • Chart 12 7: Atherectomy Disposables Market, Asia-Pacific, 2016 - 2026
  • Chart 12 8: CTO Device Market, Asia-Pacific, 2016 - 2026
  • Chart 12 9: Stent Graft Market by Segment, Asia-Pacific, 2016 - 2026
  • Chart 12 10: Surgical Graft Market by Segment, Asia-Pacific, 2016 - 2026
  • Chart 12 11: Diagnostic & Interventional Guidewire Market by Segment, Asia-Pacific, 2016 - 2026
  • Chart 12 12: Diagnostic & Interventional Catheter Market by Segment, Asia-Pacific, 2016 - 2026
  • Chart 12 13: Introducer Sheath Market, Asia-Pacific, 2016 - 2026
  • Chart 12 14: VCD Market by Segment, Asia-Pacific, 2016 - 2026
  • Chart 12 15: Peripheral IVUS Catheter Market, Asia-Pacific, 2016 - 2026
  • Chart 13 1: Lithotripsy Market by Region, Global, 2016 - 2026
  • Chart 13 2: Lithotripsy Market by Region, Global, 2019
  • Chart 13 3: Lithotripsy Market by Region, Global, 2026
  • Chart 13 4: Lithotripsy Market, Global, 2016 - 2026
  • Chart 13 5: Lithotripsy Market, U.S., 2016 - 2026
  • Chart 13 6: Lithotripsy Market, Western Europe, 2016 - 2026
  • Chart 13 7: Lithotripsy Market, Rest of the World, 2016 - 2026

LIST OF FIGURES

  • Figure 1 1: Peripheral Vascular Device Market Share Ranking by Segment, Global, 2019
  • Figure 1 2: Companies Researched in this Report (1 of 2)
  • Figure 1 3: Companies Researched in this Report (2 of 2)
  • Figure 1 4: Factors Impacting the Peripheral Vascular Device Market by Segment, Global (1 of 2)
  • Figure 1 5: Factors Impacting the Peripheral Vascular Device Market by Segment, Global (2 of 2)
  • Figure 1 6: Recent Events in the Peripheral Vascular Device Market, Global, 2016 - 2019
  • Figure 1 7: Peripheral Vascular Procedures Covered
  • Figure 1 8: Peripheral Vascular Markets Covered (1 of 2)
  • Figure 1 9: Peripheral Vascular Markets Covered (2 of 2)
  • Figure 1 10: Version History
  • Figure 3 1: Peripheral Vascular Stent by Company (1 of 2)
  • Figure 3 2: Peripheral Vascular Stent by Company (2 of 2)
  • Figure 3 3: Venous Stent by Company
  • Figure 3 4: PTA Balloon Catheter by Company (1 of 3)
  • Figure 3 5: PTA Balloon Catheter by Company (2 of 3)
  • Figure 3 6: PTA Balloon Catheter by Company (3 of 3)
  • Figure 3 7: Drug-Coated Balloon by Company
  • Figure 3 8: Atherectomy Device by Company
  • Figure 3 9: Chronic Total Occlusion Device by Company
  • Figure 3 10: Lithotripsy Device by Company
  • Figure 3 11: Surgical Graft by Company (1 of 2)
  • Figure 3 12: Surgical Graft by Company (2 of 2)
  • Figure 3 13: Stent Graft by Company
  • Figure 3 14: Embolic Protection Device by Company
  • Figure 3 15: Peripheral Thrombus Management by Company
  • Figure 3 16: Inferior Vena Cava Filter by Company
  • Figure 3 17: Carotid Shunt by Company
  • Figure 3 18: Diagnostic and Interventional Catheters by Company (1 of 2)
  • Figure 3 19: Diagnostic and Interventional Catheters by Company (2 of 2)
  • Figure 3 20: Diagnostic and Interventional Guidewire by Company (1 of 3)
  • Figure 3 21: Diagnostic and Interventional Guidewire by Company (2 of 3)
  • Figure 3 22: Diagnostic and Interventional Guidewire by Company (3 of 3)
  • Figure 3 23: Introducer Sheath by Company (1 of 4)
  • Figure 3 24: Introducer Sheath by Company (2 of 4)
  • Figure 3 25: Introducer Sheath by Company (3 of 4)
  • Figure 3 26: Introducer Sheath by Company (4 of 4)
  • Figure 3 27: Vascular Closure Device by Company (1 of 2)
  • Figure 3 28: Vascular Closure Device by Company (2 of 2)
  • Figure 3 29: Transcatheter Embolization Devices by Company (1 of 2)
  • Figure 3 30: Transcatheter Embolization Devices by Company (2 of 2)
  • Figure 3 31: Peripheral IVUS Catheter by Company
  • Figure 3 32: Class 2 Device Recall RX ACCULINK Carotid Stent System
  • Figure 3 33: Class 2 Device Recall StarClose SE Vascular Closure System, Abbot
  • Figure 3 34: Class 2 Device Recall ClosureFast Micro Introducer Sheath Set, Argon Medical
  • Figure 3 35: Class 2 Device Recall Super ArrowFlex Percutaneous Sheath Introducer Sets, Arrow
  • Figure 3 36: Class 2 Device Recall Percutaneous Sheath Introducer Kit, Arrow
  • Figure 3 37: Class 2 Device Recall Super ArrowFlex(R) Percutaneous Sheath Introducer Set with Integral Hemostasis Valve/Side Port, Arrow
  • Figure 3 38: Class 2 Device Recall Arrow
  • Figure 3 39: Class 2 Device Recall Arrow Percutaneous Sheath Introducer Kits, Arrow
  • Figure 3 40: Class 2 Device Recall iCAST and Advanta
  • Figure 3 41: Class 2 Device Recall Denali Filter Femoral Delivery System, Bard Peripheral Vascular Inc
  • Figure 3 42: Class 2 Device Recall Denali Filter Jugular Subclavian Delivery System, Bard Peripheral Vascular Inc
  • Figure 3 43: Class 1 Device Recall Bard Peripheral Vascular
  • Figure 3 44: Class 2 Device Recall FLAIR Endovascular Stent Graft, Bard Peripheral Vascular Inc
  • Figure 3 45: Class 2 Device Recall, Boston Scientific
  • Figure 3 46: Class 1 Device Recall Boston Scientific
  • Figure 3 47: Class 2 Device Recall Boston Scientific Imager II Angiographic Catheter
  • Figure 3 48: Class 2 Device Recall IMAGER II Angiographic Catheters
  • Figure 3 49: Class 2 Device Recall Guider Softip XF
  • Figure 3 50: Class 1 Device Recall Boston Scientific
  • Figure 3 51: Class 2 Device Recall Zurpaz(TM) MEDIUM CURL, ASYMMETRIC CURVE, Steerable Sheath
  • Figure 3 52: Class 1 Device Recall Chariot" Guiding Sheath
  • Figure 3 53: Device Recall AngioJet Ultra 5000 A Console, Boston Scientific
  • Figure 3 54: Class 2 Device Recall AngioJet Thrombectomy Set, Boston Scientific
  • Figure 3 55: Class 2 Device Recall Cardinal Health
  • Figure 3 56: Class 2 Device Recall ViperWire Advance with Flextip Peripheral Atherectomy Guide Wire, Cardiovascular Systems Inc
  • Figure 3 57: Class 2 Device Recall ViperWire Advance with Flextip Peripheral Atherectomy Guide Wire, Cardiovascular Systems Inc
  • Figure 3 58: Class 2 Device Recall DIAMONDBACK 360 Peripheral Orbital Atherectomy System, Cardiovascular Systems Inc
  • Figure 3 59: Class 2 Device Recall ViperWire Advance peripheral guide wire, Cardiovascular Systems Inc
  • Figure 3 60: Class 1 Device Recall Diamondback 360 Peripheral Orbital Atherectomy System
  • Figure 3 61: Class 2 Device Recall SlipCath Beacon Tip Catheter
  • Figure 3 62: Class 2 Device Recall CheckFlo Performer Introducer Set
  • Figure 3 63: Class 2 Device Recall Micropuncture CheckFlo Performer Introducer Set
  • Figure 3 64: Class 2 Device Recall CheckFlo Introducer HausdorfLock Atrial
  • Figure 3 65: Class 3 Device Recall Gunther Tulip Vena Cava Filter Set
  • Figure 3 66: Class 3 Device Recall Cook Celect Platinum Vena Cava Filter Set
  • Figure 3 67: Class 2 Device Recall Cook Medical
  • Figure 3 68: Class 2 Device Recall Zenith Alpha Abdominal Endovascular Graft
  • Figure 3 69: Class 1 Device Recall Zenith Alpha Thoracic Endovascular Graft
  • Figure 3 70: Class 3 Device Recall Cordis Vista Brite Tip AdroitTM Guiding Catheter
  • Figure 3 71: Class 2 Device Recall POWERFLEX PRO Percutaneous Transluminal Angioplasty (PTA) Catheter
  • Figure 3 72: Class 1 Device Recall OptEase Vena Cava Filter, Cordis
  • Figure 3 73: Class 2 Device Recall Cordis S.M.A.R.T. Flex Vascular Stent System
  • Figure 3 74: Class 2 Device Recall Transhepatic Biliary Stent System
  • Figure 3 75: Class 1 Device Recall ENDOLOGIX AFX2 Bifurcated Endograft System
  • Figure 3 76: Class 1 Device Recall ENDOLOGIX AFX/AFX2, Proximal (Aortic) Extension Endograft
  • Figure 3 77: Class 1 Device Recall ENDOLOGIX AFX Endovascular AAA System
  • Figure 3 78: Class 1 Device Recall ENDOLOGIX AFX/AFX2, Limb (Iliac) Extension Endograft
  • Figure 3 79: Class 2 Device Recall AFX Endovascular AAA System, Endologix
  • Figure 3 80: Class 1 Device Recall IntraClude IntraAortic Occlusion Device
  • Figure 3 81: Class 2 Device Recall IntraClude(TM) IntraAortic Occlusion Device
  • Figure 3 82: Class 2 Device Recall Edwards Lifesciences IntraClude IntraAortic Occlusion Device
  • Figure 3 83: Class 2 Device Recall Corkscrew Catheter
  • Figure 3 84: Class 1 Device Recall CS100 IntraAortic Balloon Pump
  • Figure 3 85: Class 1 Device Recall Cardiosave Hybrid IntraAortic Balloon Pump
  • Figure 3 86: Class 1 Device Recall Cardiosave Hybrid IABP
  • Figure 3 87: Class 2 Device Recall Protege Rx Tapered Carotid Stent System, Eve Inc.
  • Figure 3 88: Class 1 Device Recall Covidien
  • Figure 3 89: Class 2 Device Recall PowerCross .018 OTW PTA Dilation Catheter, Medtronic
  • Figure 3 90: Class 2 Device Recall Ev3, Inc. (Medtronic)
  • Figure 3 91: Class 2 Device Recall Amphirion Deep OTW PTA Balloon Catheter, Medtronic
  • Figure 3 92: lass 2 Device Recall EV3 EverFiex" Selfexpanding Peripheral Stent System, Ev3 Inc.
  • Figure 3 93: Class 2 Device Recall Medtronic Aptus™ HeliFX™ Thoracic EndoAnchor™ System HeliFX Guide 42 mm, Medtronic
  • Figure 3 94: Class 2 Device Recall Endurant / Endurant II 23mm and 25mm Bifurcated Stent Graft Systems, Medtronic
  • Figure 3 95: Class 2 Device Recall FIBERNET Embolic Protection System, Medtronic
  • Figure 3 96: Class 2 Device Recall Spectranetics TurboElite Laser Atherectomy Catheters, Spectranetics
  • Figure 3 97: Class 2 Device Recall Turbo Elite Atherectomy Catheter, Spectranetics
  • Figure 3 98: Class 2 Device Recall TurboPower, Spectranetics
  • Figure 3 99: Class 1 Device Recall Bridge Balloon Catheter
  • Figure 3 100: Class 1 Device Recall Bridge Balloon
  • Figure 3 101: Class 2 Device Recall Shockwave Medical Peripheral Intravascular Lithotripsy (IVL) System
  • Figure 3 102: Class 2 Device Recall PINNACLE Introducer Sheath, Terumo
  • Figure 3 103: Class 1 Device Recall SOLOPATH Balloon Expandable TransFemoral System
  • Figure 3 104: Class 2 Device Recall DIAMONDBACK 360 Peripheral Orbital Atherectomy System
  • Figure 3 105: Class 1 Device Recall 7F Prelude Short Sheath Introducer, Merit
  • Figure 3 106: Class 2 Device Recall USE PTA 0.014 RX Catheter, Us Endovascular
  • Figure 3 107: Class 2 Device Recall Balloon Catheter, EXP Pharmaceutical Services Corp
  • Figure 3 108: Class 2 Device Recall IVUS Catheter, Volcano
  • Figure 3 109: Class 1 Device Recall Ovation Prime Abdominal Stent Graft System, TriVascular
  • Figure 3 110: Class 2 Device Recall Ovation Prime Abdominal Stent Graft System, TriVascular
  • Figure 3 111: Class 2 Device Recall MynxGrip Vascular Closure Device
  • Figure 3 112: Class 2 Device Recall Vascular closure device, EXP Pharmaceutical (OEM)
  • Figure 3 113: A Superiority Trial of the SUPERA Peripheral Stent System in Patients With Femoro-popliteal Artery Disease
  • Figure 3 114: Stella Supera Siberia
  • Figure 3 115: A Superiority Trial of the SUPERA Peripheral Stent System in Patients With Femoro-popliteal Artery Disease
  • Figure 3 116: Absolute Pro® MOMENTUM™ (MOMENTUM)
  • Figure 3 117: Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery (SUPERB)
  • Figure 3 118: Trial to Evaluate the Safety & Efficacy of the Omnilink Elite™ Peripheral Balloon-Expandable Stent System in Subjects With Atherosclerotic de Novo or Restenotic Lesions in the Native Common Iliac Artery and/or Native External Iliac Artery (MOBILITY OE)
  • Figure 3 119: Trial to Evaluate the Safety & Efficacy of the Absolute Pro™ Peripheral Self-Expanding Stent System in Subjects With Atherosclerotic de Novo or Restenotic Lesions in the Native Common Iliac Artery and/or Native External Iliac Artery. (MOBILITY AP)
  • Figure 3 120: ESPRIT I: A Clinical Evaluation of the Abbott Vascular ESPRIT BVS (Bioresorbable Vascular Scaffold) System
  • Figure 3 121: Clinical Post Market Clinical Follow-up (PMCF) on Peripheral Arteries Treated With SeQuent® Please Over The Wire (OTW)
  • Figure 3 122: "All Comers" Post Market Clinical Follow-up (PMCF) With Multi-LOC for flOw liMiting Outcomes (LOCOMOTIVE Extended)
  • Figure 3 123: Safety and Effectiveness of Jetstream Atherectomy System (J-SUPREME II)
  • Figure 3 124: Safety and Effectiveness of Jetstream Atherectomy System (J-SUPREME)
  • Figure 3 125: The Jetstream (JET) Post-market Registry (JET)
  • Figure 3 126: RANGER™ Paclitaxel Coated Balloon vs Standard Balloon Angioplasty (RANGER II SFA)
  • Figure 3 127: Compare I Pilot Study for the Treatment of Subjects With Symptomatic Femoropopliteal Artery Disease
  • Figure 3 128: An Efficacy and Safety Study to Evaluate Ranger DEB
  • Figure 3 129: Trial Comparing ELUVIA Versus Bare Metal Stent in Treatment of Superficial Femoral and/or Proximal Popliteal Artery
  • Figure 3 130: A Real World Evaluation of the ELUVIA Stent in Subjects With Lesions Located in the Femoropopliteal Arteries (REGAL)
  • Figure 3 131: Peripheral Registry of Endovascular Clinical Outcomes "The PRIME Registry" (PRIME)
  • Figure 3 132: VIRTUS: An Evaluation of the Vici™ Venous Stent System in Patients With Chronic Iliofemoral Venous Outflow Obstruction (VIRTUS)
  • Figure 3 133: Real World Registry Assessing the Clinical Use of the Bard UltraScore Forced Focus PTA Balloon
  • Figure 3 134: Lutonix Drug Coated Balloon for Treatment of Femoropopliteal Arteries in United States Females (CONFIRM)
  • Figure 3 135: Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter (SAFE-DCB)
  • Figure 3 136: Registry Investigating the Clinical Use and Safety of the Lutonix Drug Coated Balloon
  • Figure 3 137: Korean Post-market Registry Assessing the Clinical Use and Safety of the Lutonix DCB
  • Figure 3 138: BARD® The VENOVO™ Venous Stent Study for Treatment of Iliofemoral Occlusive Disease (VERNACULAR)
  • Figure 3 139: Real World Registry Assessing the Clinical Use of the Bard UltraScore Forced Focus PTA Balloon
  • Figure 3 140: Peripheral Registry of Endovascular Clinical Outcomes "The PRIME Registry" (PRIME)
  • Figure 3 141: The Safety and Efficacy of an Extravascular, Water-Soluble Sealant
  • Figure 3 142: Zilver® PTX® V Clinical Study
  • Figure 3 143: Zilver Flex Post-Market Study in Japan
  • Figure 3 144: Zilver PTX Post-Market Study in Japan
  • Figure 3 145: Zilver® PTX® in China
  • Figure 3 146: Predicting the Safety and Effectiveness of Inferior Vena Cava Filters (PRESERVE)
  • Figure 3 147: Paclitaxel-coated Peripheral Stents Used in the Treatment of Femoropopliteal Stenoses (XPEDITE)
  • Figure 3 148: FORMAT Clinical Study
  • Figure 3 149: VIVO Clinical Study
  • Figure 3 150: Study of Drug Eluting Peripheral Vascular Stent System in Superficial Femoral Artery Stenosis and /or Occlusion
  • Figure 3 151: Evaluation of Safety and Efficacy of the FlexStent® Femoropopliteal Self-Expanding Stent System (OPEN)
  • Figure 3 152: JET-RANGER Trial - JETStream Atherectomy With Adjunctive Paclitaxel-Coated Balloon Angioplasty vs Plain Old Balloon Angioplasty Followed by Paclitaxel-Coated Balloon
  • Figure 3 153: DiRectional AthErectomy + Drug CoAted BaLloon to Treat Long, CalcifIed FemoropopliTeal ArterY Lesions (REALITY)
  • Figure 3 154: A Trial to Evaluate the Safety and Efficacy of the Passeo-18 Lux Drug-coated Balloon of Biotronik in the Treatment of the Femoropopliteal Artery Compared to the Medtronic IN.PACT Admiral Drug-coated Balloon. (BIOPACT-RCT)
  • Figure 3 155: Prospective Study for the Treatment of Atherosclerotic Lesions in the Superficial Femoral and/or Popliteal Arteries Using the FLEX Scoring Catheter Plus DCB (FORTEZ)
  • Figure 3 156: IN.PACT BTK Randomized Study to Assess Safety and Efficacy of IN.PACT 014 vs. PTA
  • Figure 3 157: IN.PACT Global Clinical Study
  • Figure 3 158: Compare I Pilot Study for the Treatment of Subjects With Symptomatic Femoropopliteal Artery Disease
  • Figure 3 159: DiRectional AthErectomy + Drug CoAted BaLloon to Treat Long, CalcifIed FemoropopliTeal ArterY Lesions (REALITY)
  • Figure 3 160: Comparison of Angioplasty/Drug Coated Balloon/Laser + Drug Coated Balloon for Femoropopliteal Artery In-stent Restenosis (INTACT)
  • Figure 3 161: Korean Multicenter Prospective Registry of In.PACT DEB for Isolated Popliteal Artery Disease (K-POP Study)
  • Figure 3 162: In.Pact Flexion, Investigating the Performance of the In.Pact Admiral DEB for Popliteal Lesions (INPCTFLEXION)
  • Figure 3 163: IN.PACT Admiral Drug-Coated Balloon vs. Standard Balloon Angioplasty for the Treatment of Superficial Femoral Artery (SFA) and Proximal Popliteal Artery (PPA) (INPACT SFA II)
  • Figure 3 164: Study of IN.PACT Amphirion™ Drug Eluting Balloon vs. Standard PTA for the Treatment of Below the Knee Critical Limb Ischemia (INPACT-DEEP)
  • Figure 3 165: Randomized Trial of IN.PACT Admiral® Drug Coated Balloon vs Standard PTA for the Treatment of SFA and Proximal Popliteal Arterial Disease (INPACT SFA I)
  • Figure 3 166: The IN.PACT SFA Clinical Study for the Treatment of Atherosclerotic Lesions in the Superficial Femoral Artery and/or Proximal Popliteal Artery Using the IN.PACT Admiral™ Drug-Eluting Balloon in a Chinese Patient Population
  • Figure 3 167: EverFlex Post Approval Study (DURABILITY PAS)
  • Figure 3 168: Peripheral Registry of Endovascular Clinical Outcomes "The PRIME Registry" (PRIME)
  • Figure 3 169: The Merit WRAPSODY™ Endovascular Stent Graft for Treatment of Iliac Artery Occlusive Disease
  • Figure 3 170: Radial accEss for nAvigation to Your CHosen Lesion for Peripheral Vascular Intervention: REACH PVI (REACH PVI)
  • Figure 3 171: DiRectional AthErectomy + Drug CoAted BaLloon to Treat Long, CalcifIed FemoropopliTeal ArterY Lesions (REALITY)
  • Figure 3 172: ILLUMENATE Below-The-Knee (BTK) Arteries: a Post Market Clinical Study (BTK PMS)
  • Figure 3 173: TurboPower + DCB Treatment of Femoropopliteal De Novo/ Restenotic and In-Stent Restenosis Lesions
  • Figure 3 174: ILLUMENATE Pivotal Post-Approval Study (PAS)
  • Figure 3 175: Pivotal Trial of a Novel Paclitaxel-Coated Percutaneous Angioplasty Balloon (ILLUMENATE)
  • Figure 3 176: Comparison of Angioplasty/Drug Coated Balloon/Laser + Drug Coated Balloon for Femoropopliteal Artery In-stent Restenosis (INTACT)
  • Figure 3 177: Global Study of a Drug-coated Balloon to Treat Obstructive SFA and/or Popliteal Lesions (ILLUMENATE)
  • Figure 3 178: An Evaluation of a Clinical Algorithm With Turbo-Power Following Treatment of Specific Morphologies (REX)
  • Figure 3 179: Shockwave Medical Peripheral Lithoplasty System Study for PAD (Disrupt PAD III)
  • Figure 3 180: Safety and Efficacy of the SurVeil™ Drug-Coated Balloon (TRANSCEND)
  • Figure 3 181: Safety and Feasibility of SurModics SurVeil (TM) Drug Coated Balloon (PREVEIL)
  • Figure 3 182: Treatment of Patients With Lesions in the Superficial Femoral or Popliteal Arteries Using Kanshas Drug Coated Balloon (KANSHAS1)
  • Figure 3 183: Misago® RX Self-Expanding Peripheral Stent
  • Figure 3 184: In-Stent Restenosis Post-Approval Study
  • Figure 3 185: Evaluation of the GORE TIGRIS Vascular Stent (TIGRIS)
  • Figure 3 186: A Study of the Gore VIABAHN BX for Treatment of Occlusive Disease in the Iliac Arteries. (VBXFLEX)
  • Figure 3 187: Multi-center Study for Stent Graft System for Peripheral Artery (VJH 11-01)
  • Figure 3 188: Post-Market Registry of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis Implanted in Peripheral Vessels (EXPAND)
  • Figure 3 189: " Endarterectomy Combined With Optimal Medical Therapy (OMT) vs OMT Alone in Patients With Asymptomatic Severe Atherosclerotic Carotid Artery Stenosis at Higher-than-average Risk of Ipsilateral Stroke " (ACTRIS)
  • Figure 3 190: Carotid Endarterectomy and Carotid Artery Stenting in Brazil
  • Figure 3 191: Remote Endarterectomy vs Remote Endarterectomy + Drug Coated Balloon (DCB) Angioplasty in Patients With the Femoral Artery Occlusive Disease
  • Figure 3 192: Arteriovenous Fistulae: Drug-eluting Balloon Angioplasty (FAVABED)
  • Figure 3 193: BIOLUX P-III BENELUX All-Comers Registry
  • Figure 3 194: BIOLUX P-III SPAIN All-Comers Registry
  • Figure 3 195: Drug Eluting Balloon for Early Fistula Failure Trial (DEBEFF)
  • Figure 3 196: Drug-Eluting Balloon in Arteriovenous Graft
  • Figure 3 197: Atherectomy and Drug-Coated Balloon Angioplasty in Treatment of Long Infrapopliteal Lesions (ADCAT)
  • Figure 3 198: Drug-Coated Chocolate PTA Balloon in Patients With Peripheral Arterial Disease - The ENDURE Trial (ENDURE)
  • Figure 3 199: AcoArt II/ BTK China: Drug-eluting Balloon for Below-The-Knee Angioplasty Evaluation in China
  • Figure 3 200: AcoArt II/ BTK China: Drug-eluting Balloon for Below-The-Knee Angioplasty Evaluation in China
  • Figure 3 201: Drug-eluting Balloon vs. Conventional Balloon in the Treatment of (re)Stenosis - a Randomized Prospective Study (DRECOREST1)
  • Figure 3 202: Stella Supera Siberia
  • Figure 3 203: Study to Determine the Performance of the Astron and Pulsar-18 Stents in Europe (BIOFLEX-I EU)
  • Figure 3 204: Clinical Study of Passeo-18 Lux Balloon Catheter for the Treatment of Atherosclerotic Lesions(BIOLUX-P IV CHINA)
  • Figure 3 205: Investigational Device Exemption Study to Determine the Safety and Efficacy of the Astron and Pulsar Stents (BIOFLEX-I)
  • Figure 3 206: Evaluation of Safety and Efficacy of the FlexStent® Femoropopliteal Self-Expanding Stent System (OPEN)
  • Figure 3 207: Remedy, Biodegradable Peripheral Stent Registry
  • Figure 3 208: BIOLUX P-III All-Comers Passeo-18 Lux Registry
  • Figure 3 209: BIOTRONIK 4French for AMBulatory Peripheral Intervention (BIO4AMB)
  • Figure 4 1: Peripheral Vascular Device Market by Segment, Global, 2016 - 2026 (US$M) (1 of 2)
  • Figure 4 2: Peripheral Vascular Device Market by Segment, Global, 2016 - 2026 (US$M) (2 of 2)
  • Figure 4 3: Peripheral Vascular Device Market Growth by Segment, Global, 2016 - 2026 (1 of 2)
  • Figure 4 4: Peripheral Vascular Device Market Growth by Segment, Global, 2016 - 2026 (2 of 2)
  • Figure 4 5: Drivers and Limiters, Peripheral Vascular Market, Global, 2019
  • Figure 4 6: Leading Competitors, Peripheral Vascular Device Market, Global, 2019
  • Figure 4 7: SWOT Analysis, Abbott
  • Figure 4 8: SWOT Analysis, B. Braun
  • Figure 4 9: SWOT Analysis, Boston Scientific
  • Figure 4 10: SWOT Analysis, Cardinal Health
  • Figure 4 11: SWOT Analysis, Cook Medical
  • Figure 4 12: SWOT Analysis, Integra Lifesciences
  • Figure 4 13: SWOT Analysis, Maquet
  • Figure 4 14: SWOT Analysis, Medtronic
  • Figure 4 15: SWOT Analysis, Merit Medical
  • Figure 4 16: SWOT Analysis, Phillips
  • Figure 4 17: SWOT Analysis, Teleflex
  • Figure 4 18: SWOT Analysis, Terumo
  • Figure 4 19: SWOT Analysis, W.L. Gore
  • Figure 5 1: Procedures by Segment, Global, 2016 - 2026 (1 of 2)
  • Figure 5 2: Procedures by Segment, Global, 2016 - 2026 (2 of 2)
  • Figure 5 3: Bare-Metal Stent Procedures by Indication, Global, 2016 - 2026
  • Figure 5 4: Stent Graft Procedures by Indication, Global, 2016 - 2026
  • Figure 5 5: Surgical Graft Procedures by Indication, Global, 2016 - 2026
  • Figure 5 6: Procedures by Segment, North America, 2016 - 2026 (1 of 2)
  • Figure 5 7: Procedures by Segment, North America, 2016 - 2026 (2 of 2)
  • Figure 5 8: Bare-Metal Stent Procedures by Indication, North America, 2016 - 2026
  • Figure 5 9: Stent Graft Procedures by Indication, North America, 2016 - 2026
  • Figure 5 10: Surgical Graft Procedures by Indication, North America, 2016 - 2026
  • Figure 5 11: Procedures by Segment, Latin America, 2016 - 2026 (1 of 2)
  • Figure 5 12: Procedures by Segment, Latin America, 2016 - 2026 (2 of 2)
  • Figure 5 13: Bare-Metal Stent Procedures by Indication, Latin America, 2016 - 2026
  • Figure 5 14: Stent Graft Procedures by Indication, Latin America, 2016 - 2026
  • Figure 5 15: Surgical Graft Procedures by Indication, Latin America, 2016 - 2026
  • Figure 5 16: Procedures by Segment, Western Europe, 2016 - 2026 (1 of 2)
  • Figure 5 17: Procedures by Segment, Western Europe, 2016 - 2026 (2 of 2)
  • Figure 5 18: Bare-Metal Stent Procedures by Indication, Western Europe, 2016 - 2026
  • Figure 5 19: Stent Graft Procedures by Indication, Western Europe, 2016 - 2026
  • Figure 5 20: Surgical Graft Procedures by Indication, Western Europe, 2016 - 2026
  • Figure 5 21: Procedures by Segment, Central & Eastern Europe, 2016 - 2026 (1 of 2)
  • Figure 5 22: Procedures by Segment, Central & Eastern Europe, 2016 - 2026 (2 of 2)
  • Figure 5 23: Bare-Metal Stent Procedures by Indication, Central & Eastern Europe, 2016 - 2026
  • Figure 5 24: Stent Graft Procedures by Indication, Central & Eastern Europe, 2016 - 2026
  • Figure 5 25: Surgical Graft Procedures by Indication, Central & Eastern Europe, 2016 - 2026
  • Figure 5 26: Procedures by Segment, Middle East, 2016 - 2026 (1 of 2)
  • Figure 5 27: Procedures by Segment, Middle East, 2016 - 2026 (2 of 2)
  • Figure 5 28: Bare-Metal Stent Procedures by Indication, Middle East, 2016 - 2026
  • Figure 5 29: Stent Graft Procedures by Indication, Middle East, 2016 - 2026
  • Figure 5 30: Surgical Graft Procedures by Indication, Middle East, 2016 - 2026
  • Figure 5 31: Procedures by Segment, Africa, 2016 - 2026 (1 of 2)
  • Figure 5 32: Procedures by Segment, Africa, 2016 - 2026 (2 of 2)
  • Figure 5 33: Bare-Metal Stent Procedures by Indication, Africa, 2016 - 2026
  • Figure 5 34: Stent Graft Procedures by Indication, Africa, 2016 - 2026
  • Figure 5 35: Surgical Graft Procedures by Indication, Africa, 2016 - 2026
  • Figure 5 36: Procedures by Segment, Asia-Pacific, 2016 - 2026 (1 of 2)
  • Figure 5 37: Procedures by Segment, Asia-Pacific, 2016 - 2026 (2 of 2)
  • Figure 5 38: Bare-Metal Stent Procedures by Indication, Asia-Pacific, 2016 - 2026
  • Figure 5 39: Stent Graft Procedures by Indication, Asia-Pacific, 2016 - 2026
  • Figure 5 40: Surgical Graft Procedures by Indication, Asia-Pacific, 2016 - 2026
  • Figure 6 1: Peripheral Vascular Device Market by Segment, North America, 2016 - 2026 (US$M) (1 of 2)
  • Figure 6 2: Peripheral Vascular Device Market by Segment, North America, 2016 - 2026 (US$M) (2 of 2)
  • Figure 6 3: Peripheral Vascular Stent Market by Segment, North America, 2016 - 2026 (US$M)
  • Figure 6 4: Total Peripheral Vascular Stent Market, North America, 2016 - 2026
  • Figure 6 5: Total Bare-Metal Stent Market, North America, 2016 - 2026
  • Figure 6 6: Bare-Metal Carotid Artery Stent Market, North America, 2016 - 2026
  • Figure 6 7: Bare-Metal Renal Stent Market, North America, 2016 - 2026
  • Figure 6 8: Bare-Metal Iliac Stent Market, North America, 2016 - 2026
  • Figure 6 9: Bare-Metal Fem-Popliteal Stent Market, North America, 2016 - 2026
  • Figure 6 10: Bare-Metal Infra-Popliteal Stent Market, North America, 2016 - 2026
  • Figure 6 11: Covered Stent Market, North America, 2016 - 2026
  • Figure 6 12: Drug-Eluting Stent Market, North America, 2016 - 2026
  • Figure 6 13: PTA Balloon Catheter Market, North America, 2016 - 2026
  • Figure 6 14: Drug Coated Balloon Market, North America, 2016 - 2026
  • Figure 6 15: Atherectomy Disposables Market, North America, 2016 - 2026
  • Figure 6 16: Chronic Total Occlusion Device Market, North America, 2016 - 2026
  • Figure 6 17: Stent Graft Market by Segment, North America, 2016 - 2026 (US$M)
  • Figure 6 18: Total Stent Graft Market, North America, 2016 - 2026
  • Figure 6 19: AAA Stent Graft Market, North America, 2016 - 2026
  • Figure 6 20: TAA Stent Graft Market, North America, 2016 - 2026
  • Figure 6 21: FAA Stent Graft Market, North America, 2016 - 2026
  • Figure 6 22: Surgical Graft Market by Segment, North America, 2016 - 2026 (US$M)
  • Figure 6 23: Total Surgical Graft Market, North America, 2016 - 2026
  • Figure 6 24: Total Aorta Repair Surgical Graft Market, North America, 2016 - 2026
  • Figure 6 25: AAA Surgical Graft Market, North America, 2016 - 2026
  • Figure 6 26: TAA Surgical Graft Market, North America, 2016 - 2026
  • Figure 6 27: Lower Limb Surgical Graft Market, North America, 2016 - 2026
  • Figure 6 28: Extra-Anatomical Surgical Graft Market, North America, 2016 - 2026
  • Figure 6 29: Diagnostic & Interventional Guidewire Market by Segment, North America, 2016 - 2026 (US$M)
  • Figure 6 30: Total Diagnostic & Interventional Guidewire Market, North America, 2016 - 2026
  • Figure 6 31: Standard Guidewire Market, North America, 2016 - 2026
  • Figure 6 32: Hydrophilic Guidewire Market, North America, 2016 - 2026
  • Figure 6 33: Diagnostic & Interventional Catheter Market by Segment, North America, 2016 - 2026 (US$M)
  • Figure 6 34: Total Diagnostic & Interventional Catheter Market, North America, 2016 - 2026
  • Figure 6 35: Diagnostic Catheter Market, North America, 2016 - 2026
  • Figure 6 36: Interventional Catheter Market, North America, 2016 - 2026
  • Figure 6 37: Introducer Sheath Market, North America, 2016 - 2026
  • Figure 6 38: VCD Market by Segment, North America, 2016 - 2026 (US$M)
  • Figure 6 39: Total VCD Market, North America, 2016 - 2026
  • Figure 6 40: Invasive VCD Market, North America, 2016 - 2026
  • Figure 6 41: Small-Bore VCD Market, North America, 2016 - 2026
  • Figure 6 42: Large-Bore VCD Market, North America, 2016 - 2026
  • Figure 6 43: Non-Invasive VCD Market, North America, 2016 - 2026
  • Figure 6 44: Peripheral IVUS Catheter Market, North America, 2016 - 2026
  • Figure 7 1: Peripheral Vascular Device Market by Segment, Latin America, 2016 - 2026 (US$M) (1 of 2)
  • Figure 7 2: Peripheral Vascular Device Market by Segment, Latin America, 2016 - 2026 (US$M) (2 of 2)
  • Figure 7 3: Peripheral Vascular Stent Market by Segment, Latin America, 2016 - 2026 (US$M)
  • Figure 7 4: Total Peripheral Vascular Stent Market, Latin America, 2016 - 2026
  • Figure 7 5: Total Bare-Metal Stent Market, Latin America, 2016 - 2026
  • Figure 7 6: Bare-Metal Carotid Artery Stent Market, Latin America, 2016 - 2026
  • Figure 7 7: Bare-Metal Renal Stent Market, Latin America, 2016 - 2026
  • Figure 7 8: Bare-Metal Iliac Stent Market, Latin America, 2016 - 2026
  • Figure 7 9: Bare-Metal Fem-Popliteal Stent Market, Latin America, 2016 - 2026
  • Figure 7 10: Bare-Metal Infra-Popliteal Stent Market, Latin America, 2016 - 2026
  • Figure 7 11: Covered Stent Market, Latin America, 2016 - 2026
  • Figure 7 12: Drug-Eluting Stent Market, Latin America, 2016 - 2026
  • Figure 7 13: PTA Balloon Catheter Market, Latin America, 2016 - 2026
  • Figure 7 14: Drug Coated Balloon Market, Latin America, 2016 - 2026
  • Figure 7 15: Atherectomy Disposables Market, Latin America, 2016 - 2026
  • Figure 7 16: CTO Device Market, Latin America, 2016 - 2026
  • Figure 7 17: Stent Graft Market by Segment, Latin America, 2016 - 2026 (US$M)
  • Figure 7 18: Total Stent Graft Market, Latin America, 2016 - 2026
  • Figure 7 19: AAA Stent Graft Market, Latin America, 2016 - 2026
  • Figure 7 20: TAA Stent Graft Market, Latin America, 2016 - 2026
  • Figure 7 21: FAA Stent Graft Market, Latin America, 2016 - 2026
  • Figure 7 22: Surgical Graft Market by Segment, Latin America, 2016 - 2026 (US$M)
  • Figure 7 23: Total Surgical Graft Market, Latin America, 2016 - 2026
  • Figure 7 24: Total Aorta Repair Surgical Graft Market, Latin America, 2016 - 2026
  • Figure 7 25: AAA Surgical Graft Market, Latin America, 2016 - 2026
  • Figure 7 26: TAA Surgical Graft Market, Latin America, 2016 - 2026
  • Figure 7 27: Lower Limb Surgical Graft Market, Latin America, 2016 - 2026
  • Figure 7 28: Extra-Anatomical Surgical Graft Market, Latin America, 2016 - 2026
  • Figure 7 29: Diagnostic & Interventional Guidewire Market by Segment, Latin America, 2016 - 2026 (US$M)
  • Figure 7 30: Total Diagnostic & Interventional Guidewire Market, Latin America, 2016 - 2026
  • Figure 7 31: Standard Guidewire Market, Latin America, 2016 - 2026
  • Figure 7 32: Hydrophilic Guidewire Market, Latin America, 2016 - 2026
  • Figure 7 33: Diagnostic & Interventional Catheter Market by Segment, Latin America, 2016 - 2026 (US$M)
  • Figure 7 34: Total Diagnostic & Interventional Catheter Market, Latin America, 2016 - 2026
  • Figure 7 35: Diagnostic Catheter Market, Latin America, 2016 - 2026
  • Figure 7 36: Interventional Catheter Market, Latin America, 2016 - 2026
  • Figure 7 37: Introducer Sheath Market, Latin America, 2016 - 2026
  • Figure 7 38: VCD Market by Segment, Latin America, 2016 - 2026 (US$M)
  • Figure 7 39: Total VCD Market, Latin America, 2016 - 2026
  • Figure 7 40: Invasive VCD Market, Latin America, 2016 - 2026
  • Figure 7 41: Small-Bore VCD Market, Latin America, 2016 - 2026
  • Figure 7 42: Large-Bore VCD Market, Latin America, 2016 - 2026
  • Figure 7 43: Non-Invasive VCD Market, Latin America, 2016 - 2026
  • Figure 7 44: Peripheral IVUS Catheter Market, Latin America, 2016 - 2026
  • Figure 8 1: Peripheral Vascular Device Market by Segment, Western Europe, 2016 - 2026 (US$M) (1 of 2)
  • Figure 8 2: Peripheral Vascular Device Market by Segment, Western Europe, 2016 - 2026 (US$M) (2 of 2)
  • Figure 8 3: Peripheral Vascular Stent Market by Segment, Western Europe, 2016 - 2026 (US$M)
  • Figure 8 4: Total Peripheral Vascular Stent Market, Western Europe, 2016 - 2026
  • Figure 8 5: Total Bare-Metal Stent Market, Western Europe, 2016 - 2026
  • Figure 8 6: Bare-Metal Carotid Artery Stent Market, Western Europe, 2016 - 2026
  • Figure 8 7: Bare-Metal Renal Stent Market, Western Europe, 2016 - 2026
  • Figure 8 8: Bare-Metal Iliac Stent Market, Western Europe, 2016 - 2026
  • Figure 8 9: Bare-Metal Fem-Popliteal Stent Market, Western Europe, 2016 - 2026
  • Figure 8 10: Bare-Metal Infra-Popliteal Stent Market, Western Europe, 2016 - 2026
  • Figure 8 11: Covered Stent Market, Western Europe, 2016 - 2026
  • Figure 8 12: Drug-Eluting Stent Market, Western Europe, 2016 - 2026
  • Figure 8 13: PTA Balloon Catheter Market, Western Europe, 2016 - 2026
  • Figure 8 14: Drug Coated Balloon Market, Western Europe, 2016 - 2026
  • Figure 8 15: Atherectomy Disposables Market, Western Europe, 2016 - 2026
  • Figure 8 16: CTO Device Market, Western Europe, 2016 - 2026